A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy

BACKGROUND: Multiple system atrophy (MSA) is a progressive, neurodegenerative disease characterized by parkinsonism, resistance to dopamine therapy, ataxia, autonomic dysfunction, and pathological accumulation of α-synuclein (α-syn) in oligodendrocytes. Neurosin (kallikrein-6) is a serine protease c...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mol Neurodegener
Huvudupphovsmän: Spencer, Brian, Valera, Elvira, Rockenstein, Edward, Trejo-Morales, Margarita, Adame, Anthony, Masliah, Eliezer
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2015
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4580347/
https://ncbi.nlm.nih.gov/pubmed/26394760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-015-0043-6
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk